Desai resigns as chief of Apotex
Executive Summary
Apotex chief executive officer and president, Jeremy Desai, has “resigned to pursue other opportunities”, with immediate effect. Jeff Watson – previously president of Global Generics – has been appointed as president and chief operating officer with responsibility for “day-to-day operations for the company on a global basis”, while vice-chairman Jack Kay will also assume the role of chief executive officer, having previously held the role before Desai’s appointment.